82 results on '"James, Stefan"'
Search Results
2. Left atrial dysfunction in bicuspid aortic valve patients with severe aortic stenosis is associated with postoperative atrial fibrillation following aortic valve replacement
3. European Society of Cardiology Quality indicators for the care and outcomes of adults undergoing transcatheter aortic valve implantation
4. Dapagliflozin in patients with myocardial infarction without diabetes or prior heart failure
5. Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines
6. Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
7. Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
8. Is the TIME study on antihypertensive therapy and chronotropic effects on cardiovascular outcomes a pragmatic trial?
9. Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)
10. Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease
11. Real world evidence: Perspectives from a European Society of Cardiology Cardiovascular Round Table with contribution from the European Medicines Agency
12. Nationwide cardiovascular risk categorization: applying the European Society of Cardiology guidelines to the Swedish National Diabetes Register
13. 518 DUAL ANTIPLATELET THERAPY DE-ESCALATION MODALITIES IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
14. 532 SEX-RELATED DIFFERENCES IN THROMBUS BURDEN IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION
15. Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)
16. Is the ESC blowing its own trumpet or should it have a deserved fanfare? The impact and power of registry data
17. Benchmarking Observational Analyses Before Using Them to Address Questions Trials Do Not Answer: An Application to Coronary Thrombus Aspiration
18. Cost–effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial
19. Myocardial infarction after elective percutaneous coronary intervention—which cardiac troponin cut-off to use?
20. Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease
21. Causes, pattern, predictors, and prognostic implications of new hospitalizations after transcatheter aortic valve implantation: a long-term nationwide observational study
22. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
23. Good general health and lack of family history influence the underestimation of cardiovascular risk: a cross-sectional study
24. Pre-operative heart failure worsens outcome after aortic valve replacement irrespective of left ventricular ejection fraction
25. Patient-tailored antithrombotic therapy following percutaneous coronary intervention
26. Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study
27. Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X-AMI trial
28. European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes
29. Radial artery access is associated with lower mortality in patients undergoing primary PCI: a report from the SWEDEHEART registry
30. EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
31. Haemorrhagic stroke and major bleeding after intervention with biological aortic valve prosthesis: risk factors and antithrombotic treatment
32. Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel
33. Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes
34. Radial versus femoral access in patients with acute coronary syndrome undergoing invasive management: A prespecified subgroup analysis from VALIDATE-SWEDEHEART
35. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk
36. Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction: a VALIDATE-SWEDEHEART substudy
37. Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden: a report from the Swedish Coronary and Angioplasty Registry (SCAAR)
38. Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention
39. Clinical use of cangrelor: nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
40. Discussion forum response from authors to letter regarding article, ‘Three questions regarding the 2017 ESC STEMI guidelines’
41. Response to letter regarding article, ‘Oxygen therapy in ST-elevation myocardial infarction’
42. Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction
43. Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014
44. Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force
45. Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration
46. Survival and incidence of cardiovascular diseases in participants in a long-distance ski race (Vasaloppet, Sweden) compared with the background population
47. Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy
48. The 2017 ESC STEMI Guidelines
49. ‘Ten Commandments’ of the 2017 ESC STEMI Guidelines
50. Importance of post-approval real-word evidence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.